Atlas Trials

Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell Cancer

Clinical trial NCT04926753 · UNKNOWN

Trial details

NCT number
NCT04926753
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer
Start date
2021-06-01
Primary completion
2022-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.